Reduced-dose Radiation Therapy to the Primary Site is Effective for High-risk Neuroblastoma: Results from a Prospective Trial

PURPOSE: For patients with high-risk neuroblastoma (HR-NB), a dose of 21 Gy to the primary tumor site after gross total resection (GTR) provides excellent local control. However, no clinical trial has specifically evaluated the optimal dose of radiation therapy (RT), and RT-related long-term toxicit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Radiat Oncol Biol Phys
Asıl Yazarlar: Casey, Dana L., Kushner, Brian H., Cheung, Nai-Kong V., Modak, Shakeel, Basu, Ellen M., Roberts, Stephen S., LaQuaglia, Michael P., Wolden, Suzanne L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6499671/
https://ncbi.nlm.nih.gov/pubmed/30763661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2019.02.004
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller